Trials / Terminated
TerminatedNCT02799823
Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Early Feasibility Trial
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- HLT Inc. · Industry
- Sex
- All
- Age
- 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and performance of the HLT System in patients with severe aortic stenosis who present at High Risk for aortic valve replacement surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | HLT Transcatheter Aortic Valve System | Transcatheter aortic valve replacement with HLT Transcatheter Aortic Valve System |
Timeline
- Start date
- 2017-04-27
- Primary completion
- 2023-01-20
- Completion
- 2023-01-20
- First posted
- 2016-06-15
- Last updated
- 2023-05-31
Locations
5 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02799823. Inclusion in this directory is not an endorsement.